Anavex Life Sciences Corp (AVXL)

[falconer66a]

The Real Story Will Be In the NYT.

Charisma isn't going to matter when the EMA approves the drug for AD. The shorts are going to [defecate in] their pants very soon.

That very much may be so. But the defecatory inducement just as likely will be the big new story in the New York Times. Whatever they say is the authenticated proof: "New Article in Major Journal Shows Anavex Has Alzheimer's Solution."

If the article turns up in JAMA (Journal of the American Medical Association), in NEJM (New England Journal of Medicine), or in Neurology, it's a done deal. No questions can be asked. The expert authors of the article will tell that blarcamesine is both safe and efficacious; working as no other drug has. A unique new drug, with safe, effective mechanisms of action, which produce astonishing therapeutic results for those with or vulnerable to Alzheimer's. This will be the kind of information that mom and pop retail stock investors will pay attention to and act on. Hundreds of thousands of them.

I marvel that anyone, today, would hold a short position with AVXL shares. But the confidence (or arrogance) of AVXL shorters seems to prevail. For those of us safely without short positions, gonna be interesting to see how this plays out.